Akihiro Kitadate

Profile Information

Affiliation: Department of Hematology, Nephrology, and Rheumatology, Akita University

Degree: Ph.D.(Mar, 2016, Akita University)
M.D.(Mar, 2009, Akita University)

Researcher number: 90791559
J-GLOBAL ID: 201801020100489456
researchmap Member ID: B000324681

Research Interests

Research Areas

Life sciences / Hematology and oncology /

Research History

Apr, 2023 - Present

Associate professor, Hematology, Nephrology, and Rheumatology, Akita University
Apr, 2022 - Mar, 2023

Associate Professor, Clinical Research Promotion and Support Center, Akita University Hospital
Sep, 2020 - Mar, 2022

Assistant Professor, Clinical Research Promotion and Support Center, Akita University Hospital
Jul, 2019 - Aug, 2020

Department of Hematology, Nephrology, and Rheumatology, Akita University
Jul, 2017 - Jun, 2019

Head physician, Division of Hematology/Oncology, Department of Medicine, Kameda Medical Center
Apr, 2016 - Jun, 2017

Akita University
Apr, 2013 - Mar, 2016

Graduate School of Medicine, Akita University
Apr, 2012 - Mar, 2013

Akita University
Apr, 2011 - Mar, 2012

Department of Hematology/Rheumatology, Akita Kousei Medical Center
Apr, 2009 - Mar, 2011

Junior Resident, Akita University

Education

Apr, 2013 - Mar, 2016

Graduate School of Medicine, Akita University
Apr, 2003 - Mar, 2009

School of Medicine, School of Medicine, Akita University

Awards

Feb, 2024

学術賞, 秋田医学会

北舘明宏
May, 2023

奨励賞, 日本骨髄腫学会

北舘明宏
Dec, 2019

ASH Abstract Achievment Award, American Society of Hematology
Feb, 2017

秋田医学会学術奨励賞, 秋田医学会

北舘明宏
Feb, 2016

JCA Scholar-In-Training Award, American Association for Cancer Research

Akihiro Kitadate
Dec, 2015

ASH Abstract Achievement Award, American Society of Hematology

Akihiro Kitadate
Jun, 2015

Japanese Society of Hematology

Major Papers

Optimizing random skin biopsies: a review of techniques and indications for intravascular large B-cell lymphoma.

Naoko Enzan, Akihiro Kitadate, Michihiro Kono

International journal of hematology, Apr 2, 2024
High baseline total lesion glycolysis predicts early progression of disease within 24 months in patients with high-tumor-burden follicular lymphoma.

Wataru Kuroki, Akihiro Kitadate, Koichi Ishiyama, Yoshihiro Kameoka, Naoto Takahashi

International journal of hematology, 116(5) 712-722, Jul 20, 2022 Peer-reviewed
Comment on skin biopsies for diagnosing intravascular lymphoma: A retrospective study of diagnostic accuracy.

Naoko Enzan, Akihiro Kitadate, Michihiro Kono

Journal of the American Academy of Dermatology, Jul 24, 2021 Peer-reviewed
Multiple myeloma with t(11;14)-associated immature phenotype has lower CD38 expression and higher BCL2 dependence.

Akihiro Kitadate, Toshiki Terao, Kentaro Narita, Sho Ikeda, Yuto Takahashi, Takafumi Tsushima, Daisuke Miura, Masami Takeuchi, Naoto Takahashi, Kosei Matsue

Cancer science, 112(9) 3645-3654, Jul 20, 2021 Peer-reviewed
Baseline total lesion glycolysis combined with interim positron emission tomography-computed tomography is a robust predictor of outcome in patients with peripheral T-cell lymphoma.

Akihiro Kitadate, Kentaro Narita, Kouta Fukumoto, Toshiki Terao, Takafumi Tsushima, Hiroki Kobayashi, Yoshiaki Abe, Daisuke Miura, Masami Takeuchi, Youichi Machida …

Cancer medicine, 9(15) 5509-5518, Jun 18, 2020 Peer-reviewed
Pre-treatment CD38-positive regulatory T cells affect the durable response to daratumumab in relapsed/refractory multiple myeloma patients.

Akihiro Kitadate, Hiroki Kobayashi, Yoshiaki Abe, Kentaro Narita, Daisuke Miura, Masami Takeuchi, Kosei Matsue

Haematologica, 105(1) e37-e40, Jan, 2020 Peer-reviewed
Sensitivity and specificity of incisional random skin biopsy for diagnosis of intravascular large B-cell lymphoma.

Kosei Matsue, Yoshiaki Abe, Akihiro Kitadate, Daisuke Miura, Kentaro Narita, Hiroki Kobayashi, Masami Takeuchi, Naoko Enzan, Atsushi Tanaka, Kengo Takeuchi

Blood, 133(11) 1257-1259, Mar 14, 2019 Peer-reviewed
Incisional random skin biopsy, not punch biopsy, is an appropriate method for diagnosis of intravascular large B-cell lymphoma: A clinicopathological study of 25 patients.

Enzan N, Kitadate A, Tanaka A, Matsue K

The British journal of dermatology, Jan, 2019 Peer-reviewed
Histone deacetylase inhibitors downregulate CCR4 expression and decrease mogamulizumab efficacy in CCR4-positive mature T-cell lymphomas.

Akihiro Kitadate, Sho Ikeda, Fumito Abe, Naoto Takahashi, Norio Shimizu, Kosei Matsue, Hiroyuki Tagawa

Haematologica, 103(1) 126-135, Jan, 2018 Peer-reviewed
Histone deacetylase inhibitors inhibit metastasis by restoring a tumor suppressive microRNA-150 in advanced cutaneous T-cell lymphoma.

Fumito Abe, Akihiro Kitadate, Sho Ikeda, Junsuke Yamashita, Hiroki Nakanishi, Naoto Takahashi, Chikara Asaka, Kazuaki Teshima, Tomomitsu Miyagaki, Makoto Sugaya …

Oncotarget, 8(5) 7572-7585, Jan 31, 2017 Peer-reviewed
MicroRNA-16 mediates the regulation of a senescence-apoptosis switch in cutaneous T-cell and other non-Hodgkin lymphomas

A. Kitadate, S. Ikeda, K. Teshima, M. Ito, I. Toyota, N. Hasunuma, N. Takahashi, T. Miyagaki, M. Sugaya, H. Tagawa

ONCOGENE, 35(28) 3692-3704, Jul, 2016 Peer-reviewed

Misc.

【多発性骨髄腫と類縁疾患】MGUSの中に潜むMGRSの概念とそのマネージメント

黒木航, 北舘明宏

日本内科学会雑誌, 112(7) 1216-1222, Jul, 2023
【新リンパ腫学-基礎・臨床の最新動向-】悪性リンパ腫診療に求められる疾患背景因子の基礎知識自己免疫疾患・慢性炎症と悪性リンパ腫

黒木航, 北舘明宏

日本臨床, 81(増刊3 新リンパ腫学) 32-35, Mar, 2023
Myeloma kidney from the perspectives of hematologist

北舘明宏

腎と透析, 92(2), 2022
血液疾患をプライマリ・ケアではどこまで診て,どのように専門医と連携をとるべきか?診断・治療方針決定のために専門医へ速やかに紹介することが望ましい場合蛋白上昇,アルブミン低値,免疫グロブリン増加

北舘明宏

Medicina, 58(13), 2021
【これだけは知っておきたい間葉系腫瘍】寛解時に点滴刺入部位より再発した節外性NK/T細胞リンパ腫

鈴木花瑠, 円山尚子, 北舘明宏, 田中厚

皮膚病診療, 42(5) 438-441, May, 2020
低用量ヒストン脱アセチル化酵素阻害薬による特発性血小板減少性紫斑病の治療

北舘明宏, 藤島直仁

血液内科, 79(6) 752-756, Dec, 2019
ヘキソキナーゼ-2は低酸素誘導性オートファジーを促進し、多発性骨髄腫のプロテアソーム阻害薬抵抗性を誘導する(Hexokinase-2(HK2) promotes hypoxia-inducible autophagy, leading to proteasome inhibitor resistance in multiple myeloma)

池田翔, 阿部史人, 北舘明宏, 高橋直人, 田川博之

日本癌学会総会記事, 78回 J-1016, Sep, 2019
血管内大細胞型B細胞リンパ腫における皮膚生検の意義

円山尚子, 北舘明宏, 末永孝生

血液内科, 79(1) 93-99, Jul, 2019
当施設における原発性マクログロブリン血症(WM)に関連した腎障害の後方視的な検討

三浦大典, 成田健太郎, 小林宏紀, 寺尾俊紀, 津島隆史, 安部佳亮, 北舘明宏, 竹内正美, 末永孝生

日本リンパ網内系学会会誌, 59 122-122, May, 2019
血管内大細胞型B細胞リンパ腫の診断のためのFDG-PET/CT、骨髄生検、無作為的皮膚生検(FDG-PET/CT, bone marrow biopsy and random random skin biopsy for the diagnosis of intravascular large B-cell lymphoma)

成田健太郎, 北舘明宏, 安部佳亮, 小林宏紀, 三浦大典, 竹内正美, 末永孝生

日本リンパ網内系学会会誌, 59 126-126, May, 2019
赤芽球癆を伴うT細胞大顆粒リンパ球性白血病の診断にflow cytometryが有効であった1例

津島隆史, 北舘明宏, 三浦大典, 小林宏紀, 安部佳亮, 成田健太郎, 竹内正美, 末永孝生

臨床血液, 60(5) 532-532, May, 2019
多発性骨髄腫患者における腎機能回復の予測因子(The predictive factor of renal recovery in the patients with multiple myeloma)

小林宏紀, 寺尾俊紀, 津島隆史, 安部佳亮, 三浦大典, 成田健太郎, 北舘明宏, 竹内正美, 末永孝生

International Journal of Myeloma, 9(1) 79-79, May, 2019
Hexokinase-2(HK2)は低酸素誘導性オートファジーを制御し骨髄腫細胞のプロテアソーム阻害薬耐性に寄与する(Hexokinase-2(HK2) regulates hypoxia-induced autophagy, leading to resistance of proteasome inhibitor of multiple myeloma)

池田翔, 阿部史人, 北舘明宏, 小林敬宏, 高橋直人, 田川博之

International Journal of Myeloma, 9(1) 83-83, May, 2019
t(11;14)陽性多発性骨髄腫患者の臨床的病理学的な特徴(Clinicopathological analysis of multiple myeloma carrying t(11;14))

安藤知恵, 小林宏紀, 名塚隆, 村田翼, 安部佳亮, 三浦大典, 成田健太郎, 北舘明宏, 竹内正美, 末永孝生

International Journal of Myeloma, 9(1) 111-111, May, 2019
IgG κ型リンパ形質細胞性リンパ腫に合併した軽鎖沈着症の一例(Light chain deposition disease associated with IgG-κ type lymphoplasmacytic lymphoma)

成田健太郎, 小林宏紀, 北舘明宏, 安部佳亮, 三浦大輔, 津島隆史, 竹内正美, 末永孝生

International Journal of Myeloma, 9(1) 123-123, May, 2019
Intravascular lymphoma疑診例121例の解析

円山尚子, 秋本訓秀, 吉岡未里, 田中厚, 北舘明宏, 末永孝生

日本皮膚科学会雑誌, 129(4) 590-590, Apr, 2019
Intravascular lymphoma 24例における皮膚病理の解析

円山尚子, 秋本訓秀, 吉岡未里, 田中厚, 北舘明宏, 末永孝生

日本皮膚科学会雑誌, 129(3) 401-401, Mar, 2019
血管内リンパ腫23例の臨床病理学的検討最適なランダム皮膚生検方法の検討(A clinicopathological study of 23 cases of IVL: Proposal for an optimal method of random skin biopsy)

北舘明宏, 円山尚子, 小林宏紀, 安部佳亮, 成田健太郎, 竹内正美, 田中厚, 末永孝生

臨床血液, 59(9) 1491-1491, Sep, 2018
予後予測因子としての多発性骨髄腫患者における四肢骨の異常病変の検討(Prognostic significance of medullary abnormalities in the appendicular skeleton of patients with MM)

小林宏紀, 安部佳亮, 三浦大典, 成田健太郎, 北舘明宏, 竹内正美, 末永孝生

臨床血液, 59(9) 1509-1509, Sep, 2018
多発性骨髄腫患者におけるNT-pro-BNPの予後的意義(Prognostication of survival using NT-pro-BNP in newly diagnosed patients with multiple myeloma)

小林哲也, 安部佳亮, 成田健太郎, 小林宏紀, 北舘明宏, 竹内正美, 末永孝生

臨床血液, 59(9) 1509-1509, Sep, 2018

Professional Memberships

Research Projects

T細胞リンパ腫におけるHDAC阻害剤耐性機構の解明と耐性克服の治療戦略の確立

科学研究費助成事業若手研究, 若手研究, 日本学術振興会, Apr, 2020 - Mar, 2022

北舘明宏
悪性リンパ腫におけるヒストン脱アセチル化酵素が制御するmiRNAの網羅的探索

科学研究費助成事業若手研究(B), 若手研究(B), 日本学術振興会, Apr, 2017 - Mar, 2020

北舘明宏

Profile Information

Research Interests

Research Areas

Research History

Education

Awards

Major Papers

Misc.

Professional Memberships

Research Projects

Menu

Coauthors